AstraZeneca shares owned by Archford Capital Strategies
Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Archford Capital Strategies
from 13F filings
Historical chart of Archford Capital Strategies investment in AstraZeneca
Tip: Access up to 7 years of quarterly data
All positions including AstraZeneca held by Archford Capital Strategies consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in AstraZeneca by Archford Capital Strategies
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $354k | 5.4k | 65.52 |
| 2024-09-30 | $422k | 5.4k | 78.11 |
| 2024-06-30 | $519k | 6.7k | 77.99 |
| 2024-03-31 | $451k | 6.7k | 67.75 |
| 2023-12-31 | $469k | 7.0k | 67.35 |
| 2023-09-30 | $555k | 8.2k | 67.72 |
| 2023-06-30 | $674k | 9.8k | 68.92 |
| 2023-03-31 | $545k | 7.6k | 72.05 |
| 2022-12-31 | $548k | 8.1k | 67.80 |
| 2022-09-30 | $443k | 8.1k | 54.81 |
| 2022-06-30 | $539k | 8.2k | 66.05 |
| 2021-12-31 | $489k | 8.4k | 58.26 |
| 2021-09-30 | $522k | 8.7k | 60.01 |
| 2021-06-30 | $521k | 8.7k | 59.93 |
| 2021-03-31 | $506k | 10k | 50.80 |
| 2020-12-31 | $2.5M | 48k | 50.87 |
| 2020-09-30 | $2.6M | 48k | 54.80 |
| 2020-06-30 | $2.6M | 49k | 52.90 |
| 2020-03-31 | $2.2M | 49k | 44.66 |
| 2019-12-31 | $2.4M | 48k | 49.85 |
| 2019-09-30 | $2.4M | 53k | 44.56 |
| 2019-06-30 | $2.2M | 54k | 41.28 |
| 2019-03-31 | $2.4M | 59k | 40.44 |
| 2018-12-31 | $2.3M | 60k | 37.99 |
| 2018-09-30 | $2.4M | 60k | 39.57 |
| 2018-06-30 | $2.4M | 67k | 35.12 |
| 2018-03-31 | $2.6M | 74k | 34.69 |
| 2017-12-31 | $930k | 27k | 34.69 |
| 2017-09-30 | $2.5M | 75k | 33.88 |
| 2017-06-30 | $3.0k | 75k | 0.04 |
| 2017-03-31 | $2.3M | 74k | 31.29 |
| 2016-09-30 | $2.3M | 70k | 32.84 |
| 2016-03-31 | $63k | 1.8k | 35.50 |
| 2015-12-31 | $2.1M | 61k | 34.03 |
| 2015-09-30 | $298k | 9.4k | 31.85 |
| 2015-06-30 | $377k | 5.5k | 68.43 |
| 2015-03-31 | $377k | 5.5k | 68.43 |
| 2014-12-31 | $281k | 4.0k | 70.36 |
More positions owned by Archford Capital Strategies
View all positions for Archford Capital Strategies